Quest Resource Q3 revenue down 4% to $70.4M; GAAP EPS $(0.10) vs $(0.09)

Quest Resource Holding Corp

2023-Q3 EPS reported -$0.25 revenue$219,036,423

Revenue $70.4M (-4% YoY); gross profit $12.4M (+2% YoY); gross margin expanded to 17.7% from 16.6%.
GAAP net loss per diluted share $(0.10) vs $(0.09); adjusted EPS $0.02 vs $0.04 in Q3 2022.
Adjusted EBITDA $3.7M vs $3.8M; YTD adjusted EBITDA $12.7M vs $14.1M in prior year period.
RWS integration caused ~$800K gross profit shortfall, including $500K cost adjustments and $400K billing adjustment.
Company expects sequential gross profit growth in Q4; annualized cost savings of $1.7M from RWS efficiencies starting Q4.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Quest Resource Holding Corp reported third quarter ended September 30, 2023 results: revenue Revenue was $70.4 million, EPS GAAP net loss per diluted share attributable to common stockholders was $(0.10).

Period: third quarter ended September 30, 2023
Revenue: Revenue was $70.4 million
EPS: GAAP net loss per diluted share attributable to common stockholders was $(0.10)
Result: reported results

Exact text from the filing

in environmental waste and recycling services, today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights • Revenue was $70.4 million, a 4.0% decrease compared with the third quarter of 2022. • Gross profit was $12.4 million, a 2.0% increase compared with the third quarter of 2022. • Gross margin was 17.7% of

View on SEC.gov

Browse all earnings releases →

Quest Resource Holding Corp filing history →

Source: SEC EDGAR

accession 0000950170-23-063665

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.